Lataa...
Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity
Drug resistance is a fundamental clinical concern in pediatric acute lymphoblastic leukemia (pALL), and methotrexate (MTX) is an essential chemotherapy drug administered for the treatment. In the current study, the effect of iron in response to methotrexate and its underlying mechanisms were investi...
Tallennettuna:
| Julkaisussa: | Cancer Med |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7221302/ https://ncbi.nlm.nih.gov/pubmed/32176452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2982 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|